Lazard Capital Downgrades ViroPharma (VPHM) to Neutral
Tweet
Share
E-mailGet Alerts VPHM Hot Sheet
Price: $49.96 --0%
Rating Summary:
5 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 4 | New: 14
Rating Summary:
5 Buy, 9 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 1 | Down: 4 | New: 14
Join SI Premium – FREE
Lazard Capital downgraded ViroPharma (NASDAQ: VPHM) from Buy to Neutral.
For an analyst ratings summary and ratings history on ViroPharma click here. For more ratings news on ViroPharma click here.
Shares of ViroPharma closed at $22.44 yesterday.
For an analyst ratings summary and ratings history on ViroPharma click here. For more ratings news on ViroPharma click here.
Shares of ViroPharma closed at $22.44 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Downgrades Tata Technologies (TATATECH:IN) to Underweight
- Kepler Cheuvreux Upgrades Koninklijke KPN NV (KPN:NA) (KKPNY) to Buy
- Kepler Cheuvreux Upgrades BAE Systems (BA:LN) (BAESY) to Buy
Create E-mail Alert Related Categories
DowngradesRelated Entities
LazardSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
